Previous 10 | Next 10 |
Olo ( OLO ) -32% on Q2 earnings release . CS Disco ( LAW ) -32% on Q2 earnings release . Co-Diagnostics ( CODX ) -30% on Q2 earnings release . Smith Micro Software ( SMSI ) -21% on Q2 earnings release . Illumina ( ILMN ) ...
Results of National Patient Experience Survey Show 95% Satisfaction Rate with VAZALORE 81 mg as Aspirin Therapy Choice FDA-Approved VAZALORE Delivers Fast, Reliable Absorption of Aspirin SPARTA, N.J., Aug. 12, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDA...
PLx Pharma press release ( NASDAQ: PLXP ): Q2 Non-GAAP EPS of -$0.52 misses by $0.02 . Revenue of $0.48M. Cash & Cash Equivalent Balance of $35.7 Million as of June 30, 2022 For further details see: PLx Pharma Non-GAAP EPS of -$0.52 misses by $0.02, r...
- Initiates Evaluation of Strategic Alternatives to Enhance Stockholder Value - Reports Positive Results of VAZALORE ® 81 mg Patient Experience Survey - Streamlines Sales & Marketing Plan Total Net Sales of $0.5 Million, Including $0....
SPARTA, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the pot...
SPARTA, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the pot...
SPARTA, N. J., May 20, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potenti...
PLx Pharma Inc. (PLXP) Q1 2022 Earnings Conference Call May 13, 2022 8:30 am ET Company Participants Natasha Giordano - President, Chief Executive Officer Rita O’Connor - Chief Financial Officer Mike Valentino - Executive Chairman Asif Ali - Preventative Cardiologist Janet Barth - Vice...
PLx Pharma press release (NASDAQ:PLXP): Q1 Non-GAAP EPS of -$0.66 misses by $0.04. Revenue of $2.08M misses by $0.45M. “Our solid base of VAZALORE users continues to grow, and feedback from consumers and healthcare professionals is overwhelmingly positive,” said Natasha Gio...
BUILDING A SOLID BASE OF VAZALORE ® USERS Total Net Sales of $2.1 Million in the First Quarter of 2022, an Increase of Approximately 31% from Fourth Quarter of 2021 GAAP Net Loss of ($0.39) Per Diluted Share in the First Quarter 2022; Adjusted Non-GAAP N...
News, Short Squeeze, Breakout and More Instantly...
SPARTA, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ and VAZALORE ® ,...
SPARTA, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to...
2023-04-11 06:00:00 ET 3 Tips for Finding Winning Penny Stocks in 2023 The potential for exponential growth has made penny stocks a favorite among investors seeking to capitalize on undervalued, up-and-coming companies. Penny stocks , typically defined as those trading below $5 per ...